Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer

BACKGROUND: Women receiving FEC (5 fluorouracil, epirubicin and cyclophosphamide) chemotherapy (CT) for breast cancer (BC) often experience side effects such as nausea and vomiting. Individual variations of side effects occur in patients despite similar cancer therapy. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliva, Delmy, Nilsson, Mats, Andersson, Bengt-Åke, Sharp, Lena, Lewin, Freddi, Laytragoon-Lewin, Nongnit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893496/
https://www.ncbi.nlm.nih.gov/pubmed/29657992
http://dx.doi.org/10.1016/j.ctro.2016.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893496/
https://www.ncbi.nlm.nih.gov/pubmed/29657992
http://dx.doi.org/10.1016/j.ctro.2016.12.001

Ejemplares similares